The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Abstract
Metronidazole has been used for the treatment of infections for >45 years and is still successfully used for the treatment of trichomoniasis, amoebiasis, and giardiasis. Anaerobic bacterial infections caused by Bacteroides species, fusobacteria, and clostridia respond favorably to metronidazole therapy. Good clinical results in the treatment of vaginosis due to Gardnerella vaginalis have also been reported. Rates of resistance to metronidazole are still generally low; however, several studies have reported decreased susceptibility among Bacteroides species, as well as different mechanisms of resistance. Metronidazole-resistant Helicobacter pylori strains have been described, but combination therapy (eg, metronidazole, amoxicillin, or clarithromycin plus omeprazole) is still recommended for eradication of this pathogen in patients with gastroduodenal ulcers. Metronidazole is considered to be a cost-effective drug because of its low cost, good activity against pathogenic anaerobic bacteria, favorable pharmacokinetic and pharmacodynamic properties, and minor adverse effects. Metronidazole is still the criterion standard for therapy of anaerobic infections, as was described by Tally and colleagues 35 years ago.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wadsworth anaerobic bacteriology manual
Sutter, V. L., Citron, D. M., & Finegold, S. M. (1980) · Medical Entomology and Zoology · Cited by 1,388
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Human intestinal bacteria as reservoirs for antibiotic resistance genes
SALYERS, A., GUPTA, A., & WANG, Y. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.07.004 · Cited by 846
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 818
Self-citationShoemaker, N. B., Vlamakis, H., Hayes, K., & Salyers, A. A. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.2.561-568.2001 · Cited by 529
Metronidazole: A Therapeutic Review and Update
Freeman, C. D., Klutman, N. E., & Lamp, K. C. (1997) · Drugs · doi:10.2165/00003495-199754050-00003 · Cited by 473
Treatment of Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521860 · Cited by 287
Aldridge, K. E., Ashcraft, D., Cambre, K., Pierson, C. L., Jenkins, S. G., & Rosenblatt, J. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1238-1243.2001 · Cited by 230
Nguyen, M. H., Yu, V. L., Morris, A. J., McDermott, L., Wagener, M. W., Harrell, L., & Snydman, D. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313805 · Cited by 215
Review article: the treatment of refractory Helicobacter pylori infection
Mégraud, F., & Lamouliatte, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01592.x · Cited by 211
The role of Bacteroides conjugative transposons in the dissemination of antibiotic resistance genes
Whittle, G., Shoemaker, N. B., & Salyers, A. A. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180200004 · Cited by 184
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
Hedberg, M. H., & Nord, C. E. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00674.x · Cited by 182
Self-citationFourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
Wybo, I., Van den Bossche, D., Soetens, O., Vekens, E., Vandoorslaer, K., Claeys, G., Glupczynski, Y., Ieven, M., Melin, P., Nonhoff, C., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt344 · Cited by 164
Adamsson, I., Nord, C. E., Lundquist, P. G., Sjöstedt, S., & Edlund, C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.629 · Cited by 146
Self-citationAnaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing
Hecht, D. W. (2005) · Anaerobe · doi:10.1016/j.anaerobe.2005.10.004 · Cited by 137
Scott, K. P. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s000180200007 · Cited by 113
Susceptibility of the Bacteroides fragilis group in the United States in 1981
Tally, F. P., Cuchural, G. J., Jacobus, N. V., Gorbach, S. L., Aldridge, K. E., Cleary, T. J., Finegold, S. M., Hill, G. B., Iannini, P. B., McCloskey, R. V., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.4.536 · Cited by 109
Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa
Land, K. M., & Johnson, P. J. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0104 · Cited by 94
Metronidazole versus anaerobes. In vitro data and initial clinical observations.
Tally, F. P., Sutter, V. L., & Finegold, S. M. (1972) · PubMed · Cited by 90
Structural Basis of 5-Nitroimidazole Antibiotic Resistance
Leiros, H. S., Kozielski-Stuhrmann, S., Kapp, U., Terradot, L., Leonard, G. A., & McSweeney, S. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408044200 · Cited by 86
Efflux Pump Overexpression in Multiple-Antibiotic-Resistant Mutants of Bacteroides fragilis
Pumbwe, L., Glass, D., & Wexler, H. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00141-06 · Cited by 69
Sander, P., Papavinasasundaram, K. G., Dick, T., Stavropoulos, E., Ellrott, K., Springer, B., Colston, M. J., & Böttger, E. C. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3562-3568.2001 · Cited by 63
Bacteroides species highly resistant to metronidazole: an emerging clinical problem?
Rotimi, V. O., Khoursheed, M., Brazier, J. S., Jamal, W. Y., & Khodakhast, F. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00531.x · Cited by 61
Theron, M. M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh270 · Cited by 58
Clinical Management of Clostridium difficile-Associated Disease
Miller, M. A. (2007) · Clinical Infectious Diseases · doi:10.1086/519257 · Cited by 52
Treatment of clostridium difficile infection
Stroehlein, J. R. (2004) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-004-0044-y · Cited by 44
Diniz, C. G., Arantes, R. M. E., Cara, D. C., de Lima, F. L., Nicoli, J. R., de Carvalho, M. A. R., & Farias, L. M. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00052-7 · Cited by 34
Toprak, N. Ü., Çelik, C., Çakıcı, Ö. A., et al. (2004) · Anaerobe · doi:10.1016/j.anaerobe.2004.05.005 · Cited by 26
Antimicrobial resistance and the management of anaerobic infections
Boyanova, L., Kolarov, R., & Mitov, I. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.685 · Cited by 21
Matthaiou, D. K., Peppas, G., Bliziotis, I. A., & Falagas, M. E. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.04.005 · Cited by 17
Cited by
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Dharmaraja, A. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01243 · Cited by 582
Xue, J., He, M., Liu, H., Niu, Y., Crawford, A., Coates, P. D., Chen, D., Shi, R., & Zhang, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.060 · Cited by 358
Uberoi, A., Bartow-McKenney, C., Zheng, Q., Flowers, L., Campbell, A., Knight, S. A. B., Chan, N., Wei, M., Lovins, V., Bugayev, J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.011 · Cited by 324
Metadata
- Authors
- Löfmark, S., Edlund, C., & Nord, C. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01
- Volume
- 50
- Issue
- s1
- Pages
- S16-S23
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2112972569
- Cited by
- 656
- References
- 30
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.